Want to join the conversation?
For 1Q16, $PYPL expects net revenue growth of 19-21% on an FX-neutral basis and 16-18% at current spot rates to range of $2.47-2.52Bil. $PYPL anticipates that currency will be about 3 point headwind on net revenues. $PYPL sees GAAP EPS of $0.26-0.28 and non-GAAP EPS of $0.34-0.36 for 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?